The results showed that GAS2 silencing significantly suppressed the growth of T‐ALL cells from newly diagnosed patients (n = 5) and relapsed patients (n = 3) (Fig. 1D); however, this action did not perturb the growth of normal CD3+ cells (n = 5). The gene discussed is GAS2; the disease is acute lymphoblastic leukemia.